You are here

  • Home
  • Archive
  • Volume 77, Issue 2
  • Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
Anticitrullinated protein/peptide antibody multiplexing defines an extended group of ACPA-positive rheumatoid arthritis patients with distinct genetic and environmental determinants

 

Online download statistics by month:

Online download statistics by month: October 2017 to March 2024

AbstractFullPdf
Oct 20173947346
Nov 20173074526
Dec 20171943022
Jan 201870913969
Feb 20184419054
Mar 20182335023
Apr 20181734019
May 20182092917
Jun 20181952114
Jul 20181362718
Aug 2018102118
Sep 20181262013
Oct 2018104126
Nov 20181151711
Dec 20181161911
Jan 2019100259
Feb 2019114136
Mar 201913463
Apr 201971148
May 2019501110
Jun 201961128
Jul 20197966
Aug 2019129116
Sep 201989148
Oct 20196786
Nov 20198963
Dec 20197654
Jan 20206754
Feb 20205552
Mar 20207684
Apr 20206053
May 20207634
Jun 20205030
Jul 20205011
Aug 20203450
Sep 20205911
Oct 20204421
Nov 20203811
Dec 20205664
Jan 20215692
Feb 20214621
Mar 20213421
Apr 20213745
May 20211620
Jun 2021633
Jul 2021553
Aug 202113122
Sep 202112102
Oct 20213753
Nov 202189102
Dec 20216072
Jan 20227897
Feb 20222832
Mar 202212252
Apr 20226751
May 20228494
Jun 20227333
Jul 20229885
Aug 202214194
Sep 202216186
Oct 20225573
Nov 202261100
Dec 20226072
Jan 202365103
Feb 20239754
Mar 20234383
Apr 20232710
May 20237571
Jun 20232231
Jul 20233423
Aug 20232032
Sep 20231662
Oct 20236810
Nov 202310060
Dec 202377111
Jan 2024223103
Feb 20247172
Mar 202480154
Total77351048553